Page last updated: 2024-08-24

triazoles and Precancerous Conditions

triazoles has been researched along with Precancerous Conditions in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (14.29)	18.7374
1990's	2 (28.57)	18.2507
2000's	3 (42.86)	29.6817
2010's	1 (14.29)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Al-Kharboosh, R; Alamri, A; Axelrod, ML; Bouker, KB; Clarke, R; Dabydeen, SA; Díaz-Cruz, ES; Furth, PA; Hennighausen, L; Kang, K	1
Alberts, DS; Bartels, HG; Bartels, PH; Montironi, R; Scarpelli, M	1
Bonanni, B; Cassano, E; Cazzaniga, M; Decensi, A; Gandini, S; Guerrieri-Gonzaga, A; Johansson, H; Lien, EA; Luini, A; Macis, D; Oldani, S; Pelosi, G; Serrano, D	1
Nimura, H; Takayama, S; Tsutsumi, J	1
Fowler, K; Gill, K; Kirma, N; Tekmal, RR	1
Christov, K; Graves, J; Hu, L; Kelloff, G; Lubet, R; Mehta, RR; Shilkaitis, A; Steele, V; You, M	1
Hayashi, Y; Makino, S; Mori, S; Ohhara, T; Takeuchi, Y; Tochino, Y; Toyama, M	1

Trials

1 trial(s) available for triazoles and Precancerous Conditions

Article	Year
Randomized biomarker trial of anastrozole or low-dose tamoxifen or their combination in subjects with breast intraepithelial neoplasia. Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Nov-15, Volume: 15, Issue:22 Topics: Anastrozole; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast; Breast Neoplasms; Cytochrome P-450 CYP2D6; Disease-Free Survival; Female; Genotype; Humans; Nitriles; Pharmacogenetics; Precancerous Conditions; Risk; Tamoxifen; Treatment Outcome; Triazoles	2009

Article

Year

Randomized biomarker trial of anastrozole or low-dose tamoxifen or their combination in subjects with breast intraepithelial neoplasia.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Nov-15, Volume: 15, Issue:22

Topics: Anastrozole; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast; Breast Neoplasms; Cytochrome P-450 CYP2D6; Disease-Free Survival; Female; Genotype; Humans; Nitriles; Pharmacogenetics; Precancerous Conditions; Risk; Tamoxifen; Treatment Outcome; Triazoles

2009

Other Studies

6 other study(ies) available for triazoles and Precancerous Conditions

Article	Year
Comparison of tamoxifen and letrozole response in mammary preneoplasia of ER and aromatase overexpressing mice defines an immune-associated gene signature linked to tamoxifen resistance. Carcinogenesis, 2015, Volume: 36, Issue:1 Topics: Animals; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Biomarkers, Tumor; BRCA1 Protein; Drug Resistance, Neoplasm; Estrogen Receptor alpha; Female; Flow Cytometry; Gene Expression Profiling; Gene Regulatory Networks; Humans; Immune System Phenomena; Immunoenzyme Techniques; Letrozole; Mammary Neoplasms, Animal; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Nitriles; Oligonucleotide Array Sequence Analysis; Precancerous Conditions; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Tamoxifen; Triazoles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2015
Knowledge discovery processing and data mining in karyometry. Analytical and quantitative cytology and histology, 2009, Volume: 31, Issue:3 Topics: Algorithms; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Papillary; Cell Nucleus; Colonic Neoplasms; Computational Biology; Female; Humans; Karyometry; Letrozole; Neoplasm Recurrence, Local; Nitriles; Precancerous Conditions; Triazoles; Urinary Bladder Neoplasms	2009
[Biochemical and immunohistological changes in the gastric mucosa of rats with long-term administration of histamine H2-receptor antagonist]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1998, Volume: 95, Issue:12 Topics: Animals; Gastric Mucosa; Gastrins; Histamine H2 Antagonists; Male; Ornithine Decarboxylase; Peptic Ulcer; Polyamines; Precancerous Conditions; Rats; Rats, Wistar; Stomach Neoplasms; Triazoles	1998
Aromatase overexpression and breast hyperplasia, an in vivo model--continued overexpression of aromatase is sufficient to maintain hyperplasia without circulating estrogens, and aromatase inhibitors abrogate these preneoplastic changes in mammary glands. Endocrine-related cancer, 1999, Volume: 6, Issue:2 Topics: Animals; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Estrogens; Female; Hyperplasia; Letrozole; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Neoplasms, Hormone-Dependent; Nitriles; Ovariectomy; Precancerous Conditions; Receptors, Estrogen; Triazoles	1999
Bcl-2 and Bax are differentially expressed in hyperplastic, premalignant, and malignant lesions of mammary carcinogenesis. Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 2000, Volume: 11, Issue:8 Topics: Animals; Apoptosis; Aromatase Inhibitors; bcl-2-Associated X Protein; Carcinoma; Epithelial Cells; Female; Hyperplasia; Mammary Glands, Animal; Mammary Neoplasms, Animal; Precancerous Conditions; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; RNA, Messenger; Triazoles	2000
Amitrole: strain differences in morphological response of the liver following subchronic administration to mice. Toxicology letters, 1985, Volume: 29, Issue:2-3 Topics: Amitrole; Animals; Female; Hyperplasia; Immunity, Cellular; Liver; Liver Neoplasms, Experimental; Mice; Mice, Inbred Strains; Precancerous Conditions; Species Specificity; Triazoles	1985